[CAS NO. 81409-90-7]  Cabergoline

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [81409-90-7]

Store
Catalog
SLK-S5842
Brand
Selleck
CAS
81409-90-7

DESCRIPTION [81409-90-7]

Overview

MDL-
Molecular Weight451.60
Molecular FormulaC26H37N5O2
SMILESC(C=C)N1[C@]2([C@@](C=3C=4C(C2)=CNC4C=CC3)(C[C@@H](C(N(C(NCC)=O)CCCN(C)C)=O)C1)[H])[H]

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2143 mL11.0717 mL22.1435 mL
5 mM0.4429 mL2.2143 mL4.4287 mL
10 mM0.2214 mL1.1072 mL2.2143 mL
50 mM0.0443 mL0.2214 mL0.4429 mL

Description

Cabergoline (FCE-21336), an ergot derivative, is a long-acting agonist and inhibitor.

Targets

D2 receptor [1]5-HT2 [1]5-HT2B [1]D3 receptor [1]D4 receptor [1]
0.7 nM1.2 nM1.2 nM1.5 nM9 nM

In vitro

Cabergoline prevents the oxidative stress-induced cell death of cultured cortical neurons via a D2 receptor-mediated mechanism. Cabergoline suppresses the activation of ERK signaling, which might have a role in the neuroprotection. Cabergoline significantly represses extracellular glutamate accumulation triggered by oxidative stress, and increases the expression of glutamate transporters including EAAC1, which is known to be involved in the clearance of extracellular glutamate.

In vivo

Cabergoline has a long elimination half-life (63 to 109 h). An in vivo study of neuronal damage induced by intracerebroventricular (icv) injection of 6-OHDA, a neurotoxic compound that selectively damages dopaminergic neurons in male ICR mice, demonstrates that intraperitoneal (ip) administration of cabergoline for 7 days prevented nigrostriatal region dopaminergic neurons from cell death. Cabergoline also protects SH-SY5Y neuroblastoma from cell death by oxygen-glucose deprivation even when cabergoline is administered after the induction of cell death. Cabergoline increases hippocampal brain-derived neurotrophic factor (BDNF, an important regulator in the synaptic plasticity) and exerts an antidepressant effect in rats.


Synonyms

Ergoline-8-carboxamide, N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)-, (8β)-
Ergoline-8-carboxamide, N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-, (8β)-
(8β)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)ergoline-8-carboxamide
Cabergoline
Sogilen
Dostinex
Cabaser
Galastop
Cabaseril
Velactis